Related Experiment Video
Updated: Apr 15, 2026

Isolating Mesangiogenic Progenitor Cells MPCs from Human Bone Marrow
Published on: July 15, 2016
Wip1 knockout inhibits the proliferation and enhances the migration of bone marrow mesenchymal stem cells
Yiting Tang1, Lan Liu2, Ming Sheng3
1College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China; State Key Laboratory of Animal Nutrition and Key Laboratory of Farm Animal Genetic Resources and Germplasm Innovation of Ministry of Agriculture, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, China.
Abstract:
Mesenchymal stem cells (MSCs), a unique population of multipotent adult progenitor cells originally found in bone marrow (BM), are extremely useful for multifunctional therapeutic approaches. However, the growth arrest and premature senescence of MSCs in vitro prevent the in-depth characterization of these cells. In addition, the regulatory factors involved in MSCs migration remain largely unknown. Given that protein phosphorylation is associated with the processes of MSCs proliferation and migration, we focused on wild-type p53-inducible phosphatase-1 (Wip1), a well-studied modulator of phosphorylation, in this study. Our results showed that Wip1 knockout significantly inhibited MSCs proliferation and induced G2-phase cell-cycle arrest by reducing cyclinB1 expression. Compared with WT-MSCs, Wip1(-/-) MSCs displayed premature growth arrest after six passages in culture. Transwell and scratch assays revealed that Wip1(-/-) MSCs migrate more effectively than WT-MSCs. Moreover, the enhanced migratory response of Wip1(-/-) MSCs may be attributed to increases in the induction of Rac1-GTP activity, the pAKT/AKT ratio, the rearrangement of filamentous-actin (f-actin), and filopodia formation. Based on these results, we then examined the effect of treatment with a PI3K/AKT and Rac1 inhibitor, both of which impaired the migratory activity of MSCs. Therefore, we propose that the PI3K/AKT/Rac1 signaling axis mediates the Wip1 knockout-induced migration of MSCs. Our findings indicate that the principal function of Wip1 in MSCs transformation is the maintenance of proliferative capacity. Nevertheless, knocking out Wip1 increases the migratory capacity of MSCs. This dual effect of Wip1 provides the potential for purposeful routing of MSCs.
Insights
Knocking out Wip1 phosphatase inhibits mesenchymal stem cell (MSC) proliferation but enhances their migration via the PI3K/AKT/Rac1 pathway. This dual effect offers potential for targeted MSC therapies.
Area of Science:
- Stem Cell Biology
- Molecular Biology
- Cell Signaling
Background:
- Mesenchymal stem cells (MSCs) are valuable for therapy but face challenges with in vitro proliferation and senescence.
- Understanding regulators of MSC migration is crucial for therapeutic applications.
- Wild-type p53-inducible phosphatase-1 (Wip1) modulates phosphorylation, impacting cell processes.
Purpose of the Study:
- To investigate the role of Wip1 in MSC proliferation and migration.
- To elucidate the signaling pathways involved in Wip1-mediated MSC behavior.
Main Methods:
- Generated Wip1 knockout (Wip1(-/-)) and wild-type (WT) MSCs.
- Assessed proliferation, cell cycle, and migration using assays like Transwell and scratch.
- Analyzed key signaling molecules including cyclinB1, Rac1, AKT, and filamentous-actin.
Main Results:
- Wip1 knockout inhibited MSC proliferation and induced G2 cell-cycle arrest by reducing cyclinB1.
- Wip1(-/-) MSCs exhibited enhanced migration compared to WT-MSCs.
- Enhanced migration correlated with increased Rac1-GTP activity, pAKT/AKT ratio, actin rearrangement, and filopodia formation, mediated by the PI3K/AKT/Rac1 axis.
Conclusions:
- Wip1 is essential for maintaining MSC proliferative capacity.
- Wip1 deficiency enhances MSC migratory capacity through the PI3K/AKT/Rac1 pathway.
- Targeting Wip1 offers a strategy for modulating MSC behavior for therapeutic purposes.

